IP Library Patent Application 12947684
Patent Application
App. No. 12/947,684

COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-kB

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/947,684
Abstract

The present invention discloses a composition and method for effecting various cytokines and NF-κB by administering an effective amount of a phyto-percolate composition to an individual. In various exemplary embodiments, the composition is claimed to be useful for the effective treatment of inflammation, cancer, and/or various infections including HIV by regulation of various interleukins, such as IL-10 and IL-2, and of transcription factors including NF-κB.

Claims (18)

1 . A method of treating inflammation; the method comprising administering an effective amount of phyto-percolate derived from culturing microorganisms of ATCC Deposit #PTA-5863 wherein the inflammation is treated by the phyto-percolate upregulating anti-inflammatory cytokines while down regulating pro-inflammatory cytokines.

2 . The method of claim 1 , wherein the anti-inflammatory cytokines comprise IL-10 and the inflammatory cytokines comprise IL-2.

3 . The method of claim 1 , wherein the inflammatory cytokines comprise TNF-α.

4 . The method of claim 1 , wherein the inflammatory cytokines comprise IFN-γ.

5 . The method of claim 1 , wherein the anti-inflammatory cytokines comprise IL-10 and the inflammatory cytokines comprise IL-2, TNF-α, and IFN-γ.

6 . The method of claim 1 , wherein the phyto-percolate affects the expression of cytokines on a cellular level.

7 . The method of claim 1 , wherein the phyto-percolate further affects the activation of NF-κB.

8 . A method of affecting NF-κB; said method comprising administering an effective amount of phyto-percolate derived from culturing microorganisms of ATCC Deposit #PTA-5863.

9 . The method of claim 8 , wherein the affecting of NF-κB occurs by decreasing expression, activation or the DNA-binding activity of NF-κB.

10 . The method of claim 8 , wherein the affecting of NF-κB reduces inflammation.

11 . The method of claim 8 , wherein the affecting of NF-κB results in affecting various viruses.

12 . The method of claim 11 , wherein the viruses comprise the HIV virus.

13 . The method of claim 8 , wherein the affecting of NF-κB treats or prevents disorders of the immune system, including cancer.

14 . The method of claim 8 , wherein the affecting of NFκB affects host immune response.

15 . A method of affecting cytokines; said method comprising administering an effective amount of phyto-percolate derived from culturing microorganisms of ATCC Deposit #PTA-5863.

16 . The method of claim 15 , wherein the cytokines affected comprise interleukins.

17 . The method of claim 15 , wherein the cytokines affected comprise TNF-α.

18 . The method of claim 15 , wherein the cytokines affected comprise IL-2, IL-10, IL-17A, and IL-17 and the affecting of the IL-2, IL-10, IL-17A, and IL-17 results in the regulation of the immune response.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE A IN ITS ENTIRETY PREVIOUSLY RECORDED ON REEL 027531 FRAME 0882. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Mar 5, 2012
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: HEP INVESTMENTS LLC
Reel/Frame 027808/0553 →
SECURITY AGREEMENT Recorded Jan 13, 2012
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: HEP INVESTMENTS LLC
Reel/Frame 027531/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2010
From: THOMAS, TIFFANY; SARKAR, FAZLUL; CALLEWAERT, DENNIS; DAHL, ANDREW; MARTINEZ, ENRIQUE
To: HEALTH ENHANCEMENT PRODUCTS, INC.
Reel/Frame 025383/0816 →